By leveraging high-throughput sequencing technology and placing liquid biopsy at its core, HaploX offers a comprehensive range of clinical genetic testing solutions tailored to solid tumors, encompassing the entire cancer management cycle based on clinical requirements.
Pan-Cancer Genetic Testing Assays
Minimal Residual Disease (MRD) Detection Assays
Specific-Cancer Genetic Testing Assays
Lung Cancer
Gynecologic Cancer
Hepatobiliary and Pancreatic Cancer
Gastrointestinal Cancer
Breast Cancer
Urological Cancer
Raw Data
Comprehensive
and Fast
Professional Interpretation
Anti-counterfeiting
Report
Self-developed Algorithms
Top-notch Quality
Control